Companies / Relay Therapeutics, Inc. / Activity
Activity — Relay Therapeutics, Inc.
17 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Patel Sanjiv CEO | Sell | Common Stock | $337.6K | -43K -6.13% | 661,041 0.30% of shares | medium |
| Mar 9, 2026 | Catinazzo Thomas Executive | Sell | Common Stock | $178.2K | -18K -7.11% | 231,584 0.11% of shares | medium |
| Jan 27, 2026 | Bergstrom Donald A Executive | Sell | Common Stock | $144.0K | -19K -4.28% | 422,733 0.19% of shares | medium |
| Jan 27, 2026 | Catinazzo Thomas Executive | Sell | Common Stock | $105.3K | -14K -5.22% | 250,996 0.11% of shares | medium |
| Jan 27, 2026 | Rahmer Peter Executive | Sell | Common Stock | $89.0K | -12K -4.03% | 277,964 0.13% of shares | low |
| Jan 28, 2026 | Bergstrom Donald A Executive | Sell | Common Stock | $22.7K | -3K -0.64% | 420,047 0.19% of shares | low |
| Jan 28, 2026 | Catinazzo Thomas Executive | Sell | Common Stock | $14.3K | -2K -0.68% | 249,301 0.11% of shares | low |
| Jan 28, 2026 | Rahmer Peter Executive | Sell | Common Stock | $11.4K | -1K -0.49% | 276,610 0.13% of shares | low |
| Dec 31, 2025 | Patel Sanjiv CEO | Grant | Common Stock | $3.0K | +994 +0.14% | 704,209 0.32% of shares | low |
| Dec 31, 2025 | Rahmer Peter Executive | Grant | Common Stock | $3.0K | +994 +0.29% | 338,463 0.15% of shares | low |
| Jun 9, 2026 | Borisy Alexis Director | Grant | Stock Option (Right to Buy) | — | +33K | 32,947 0.02% of shares | low |
| Jun 9, 2026 | Ingram Douglas S Director | Grant | Stock Option (Right to Buy) | — | +33K | 32,947 0.02% of shares | low |
| Jun 9, 2026 | Hill Linda a Director | Grant | Stock Option (Right to Buy) | — | +33K | 32,947 0.02% of shares | low |
| Jan 13, 2026 | Catinazzo Thomas Executive | Grant | Stock Option (Right to Buy) | — | +400K | 400,000 0.18% of shares | low |
| Jan 13, 2026 | Patel Sanjiv CEO | Grant | Stock Option (Right to Buy) | — | +1.4M | 1,450,000 0.66% of shares | low |
| Jan 13, 2026 | Bergstrom Donald A Executive | Grant | Stock Option (Right to Buy) | — | +575K | 575,000 0.26% of shares | low |
| Jan 13, 2026 | Rahmer Peter Executive | Grant | Stock Option (Right to Buy) | — | +475K | 475,000 0.22% of shares | low |